FDA Inspection Readiness for Biologics and Cell & Gene Therapy Companies
Understanding FDA Inspection Readiness for Biologics Biologics and advanced therapies such as cell and gene therapies are among the most highly regulated products in the life sciences industry. FDA inspection readiness is critical to ensure compliance with current Good Manufacturing Practices (cGMP), regulatory guidelines, and patient safety standards. Inspections assess everything from manufacturing processes to […]